Sanofi ADS (SNY) News Nov 18, 2014, 10:20 a.m. Ma
Post# of 250602
Posted On: 11/18/2014 10:20:22 AM
Sanofi ADS (SNY) News Nov 18, 2014, 10:20 a.m.
MarketWatch News on SNY
If you're looking big pharma, look no further than Actavis 11:34 a.m. Nov. 17, 2014 - The Trading Deck
Medical-bill mess is worse than you thought 5:00 a.m. Nov. 12, 2014 - Richard Eisenberg
Sanofi slumps, Fiat Chrysler rallies: Europe’s big stock movers 12:22 p.m. Oct. 29, 2014 - Sara Sjolin
Sanofi board ousts CEO Viehbacher after clash over strategy 4:25 a.m. Oct. 29, 2014 - William Horobin
Sanofi shares fall 4% after CEO resigns 3:14 a.m. Oct. 29, 2014 - Sara Sjolin
Novartis advances; Sanofi slumps: Europe’s big stock movers 11:59 a.m. Oct. 28, 2014 - Sara Sjolin
Sanofi's profit drops slightly on revamp costs 1:59 a.m. Oct. 28, 2014 - MarketWatch.com
RBS, Lloyds climb; Sanofi slips: Europe’s big stock moves 10:56 a.m. Sept. 11, 2014 - Sara Sjolin
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
Skullcandy gains on upgrade,Tesla reverses gains 1:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 3:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 11:46 a.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 9:10 a.m. Aug. 11, 2014 - Russ Britt
MannKind shares soar 23% on Sanofi deal over Afrezza 6:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 4:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Zoetis narrows full-year earnings guidance 7:12 a.m. Aug. 5, 2014 - MarketWatch.com
Sanofi profit jumps 73%; earnings outlook lifted 2:22 a.m. July 31, 2014 - MarketWatch.com
Regeneron shares jump after cholesterol drug meets test goals 10:16 a.m. July 30, 2014 - Russ Britt
Maybe Amazon will unveil a toaster today 7:08 a.m. June 18, 2014 - Marek Fuchs
Merck, Sanofi, Glaxo explore shedding older drugs 4:43 p.m. June 3, 2014 - MarketWatch.com
Loading more headlines...
Advertisement
Other News on SNY
Sanofi: Recent Plunge Is A Buying Opportunity 9:00 a.m. Today - Seeking Alpha
Companies Spending the Most on R&D 8:39 a.m. Today - 247WallSt.com
Amicus Therapeutics' Fabry disease drug candidate improves cardiac health marker 7:31 a.m. Nov. 17, 2014 - Seeking Alpha
CVRs on Lemtrada +135% following approval 7:19 a.m. Nov. 17, 2014 - Seeking Alpha
Amicus Drug Improves Marker of Heart Health in Fabry Patients 10:01 a.m. Nov. 15, 2014 - TheStreet.com
Genzyme's Lemtrada approved by the FDA 9:47 p.m. Nov. 14, 2014 - Seeking Alpha
Significant Changes In Buffett and Berkshire Hathaway Holdings 4:18 p.m. Nov. 14, 2014 - 247WallSt.com
Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences 9:23 a.m. Nov. 14, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – CMN PODD ALGN SNY 12:30 p.m. Nov. 11, 2014 - InvestorPlace.com
Actavis Says 'Let's Make A Deal' 9:42 a.m. Nov. 11, 2014 - Seeking Alpha
Sanofi/Regeneron asthma drug successful in Phase 2 trial 7:44 a.m. Nov. 11, 2014 - Seeking Alpha
MannKind Is On The Mend 7:07 p.m. Nov. 7, 2014 - Seeking Alpha
Alnylam Pharmaceuticals Staying Ridiculously Busy 11:25 a.m. Nov. 7, 2014 - Seeking Alpha
Today's Market: Earnings And News Moving These 5 Stocks 10:01 a.m. Nov. 6, 2014 - Seeking Alpha
Regeneron Plunges In What Barron's Calls A Significant Disappointment: My Analysis 8:32 a.m. Nov. 6, 2014 - Seeking Alpha
6 Dividend-Paying Stocks From Around the World 10:34 a.m. Nov. 5, 2014 - Barrons.com
MannKind’s Progress Seen More Gradual 10:25 a.m. Nov. 5, 2014 - Barrons.com
What We Learned From The MannKind 3rd Quarter Conference Call 8:27 a.m. Nov. 5, 2014 - Seeking Alpha
Diabetes Analyst: Sanofi CEO's Firing May Spell Trouble for MannKind Afrezza Partnership 1:40 p.m. Nov. 4, 2014 - TheStreet.com
MannKind Corporation Stock: MNKD Third-Quarter Earnings Takeaways 6:23 a.m. Nov. 4, 2014 - InvestorPlace.com
Loading more headlines...
Press Releases on SNY
Genzyme’s Lemtrada Approved by the FDA 9:00 p.m. Nov. 14, 2014 - BusinessWire - BZX
Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma 1:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix 8:55 a.m. Nov. 4, 2014 - PR Newswire - PRF
Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis 6:00 a.m. Nov. 4, 2014 - BusinessWire - BZX
Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older 8:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sanofi 9:00 a.m. Oct. 30, 2014 - PR Newswire - PRF
Sanofi: Sanofi Delivers Business EPS Growth of 10.3% at CER 8:34 a.m. Oct. 28, 2014 - PR Newswire - PRF
New International GPCR Consortium Formed with Pharma and Academia to Advance Structural Information about G-protein Coupled Receptors 6:00 a.m. Oct. 28, 2014 - PR Newswire - PRF
Sanofi Q3 2014 Results - Interview with Jérôme Contamine 3:00 a.m. Oct. 28, 2014 - PR Newswire - PRF
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio 10:35 a.m. Oct. 20, 2014 - BusinessWire - BZX
US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis 7:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy 8:01 a.m. Oct. 16, 2014 - GlobeNewswire
New Survey Finds Differences In Attitudes About Diabetes Based On Age 8:00 a.m. Oct. 15, 2014 - PR Newswire - PRF
Genzyme Announces Winners of Patient Advocacy Leadership (PAL) Awards 8:00 a.m. Oct. 1, 2014 - BusinessWire - BZX
Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 1:00 a.m. Sept. 30, 2014 - PR Newswire - PRF
Scanning Pharma Equities - Novo Nordisk, Teva Pharma Industries, Sanofi, Valeant Pharma Intl., and Eli Lilly 9:10 a.m. Sept. 26, 2014 - PR Newswire - PRF
Genzyme Collaborates on Gene Therapy for Rare Disease that Causes Childhood Blindness 8:00 a.m. Sept. 24, 2014 - BusinessWire - BZX
Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease 8:34 a.m. Sept. 17, 2014 - PR Newswire - PRF
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies 1:00 a.m. Sept. 11, 2014 - BusinessWire - BZX
Loading more headlines...
MarketWatch News on SNY
If you're looking big pharma, look no further than Actavis 11:34 a.m. Nov. 17, 2014 - The Trading Deck
Medical-bill mess is worse than you thought 5:00 a.m. Nov. 12, 2014 - Richard Eisenberg
Sanofi slumps, Fiat Chrysler rallies: Europe’s big stock movers 12:22 p.m. Oct. 29, 2014 - Sara Sjolin
Sanofi board ousts CEO Viehbacher after clash over strategy 4:25 a.m. Oct. 29, 2014 - William Horobin
Sanofi shares fall 4% after CEO resigns 3:14 a.m. Oct. 29, 2014 - Sara Sjolin
Novartis advances; Sanofi slumps: Europe’s big stock movers 11:59 a.m. Oct. 28, 2014 - Sara Sjolin
Sanofi's profit drops slightly on revamp costs 1:59 a.m. Oct. 28, 2014 - MarketWatch.com
RBS, Lloyds climb; Sanofi slips: Europe’s big stock moves 10:56 a.m. Sept. 11, 2014 - Sara Sjolin
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
Skullcandy gains on upgrade,Tesla reverses gains 1:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 3:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 11:46 a.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 9:10 a.m. Aug. 11, 2014 - Russ Britt
MannKind shares soar 23% on Sanofi deal over Afrezza 6:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 4:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Zoetis narrows full-year earnings guidance 7:12 a.m. Aug. 5, 2014 - MarketWatch.com
Sanofi profit jumps 73%; earnings outlook lifted 2:22 a.m. July 31, 2014 - MarketWatch.com
Regeneron shares jump after cholesterol drug meets test goals 10:16 a.m. July 30, 2014 - Russ Britt
Maybe Amazon will unveil a toaster today 7:08 a.m. June 18, 2014 - Marek Fuchs
Merck, Sanofi, Glaxo explore shedding older drugs 4:43 p.m. June 3, 2014 - MarketWatch.com
Loading more headlines...
Advertisement
Other News on SNY
Sanofi: Recent Plunge Is A Buying Opportunity 9:00 a.m. Today - Seeking Alpha
Companies Spending the Most on R&D 8:39 a.m. Today - 247WallSt.com
Amicus Therapeutics' Fabry disease drug candidate improves cardiac health marker 7:31 a.m. Nov. 17, 2014 - Seeking Alpha
CVRs on Lemtrada +135% following approval 7:19 a.m. Nov. 17, 2014 - Seeking Alpha
Amicus Drug Improves Marker of Heart Health in Fabry Patients 10:01 a.m. Nov. 15, 2014 - TheStreet.com
Genzyme's Lemtrada approved by the FDA 9:47 p.m. Nov. 14, 2014 - Seeking Alpha
Significant Changes In Buffett and Berkshire Hathaway Holdings 4:18 p.m. Nov. 14, 2014 - 247WallSt.com
Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences 9:23 a.m. Nov. 14, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – CMN PODD ALGN SNY 12:30 p.m. Nov. 11, 2014 - InvestorPlace.com
Actavis Says 'Let's Make A Deal' 9:42 a.m. Nov. 11, 2014 - Seeking Alpha
Sanofi/Regeneron asthma drug successful in Phase 2 trial 7:44 a.m. Nov. 11, 2014 - Seeking Alpha
MannKind Is On The Mend 7:07 p.m. Nov. 7, 2014 - Seeking Alpha
Alnylam Pharmaceuticals Staying Ridiculously Busy 11:25 a.m. Nov. 7, 2014 - Seeking Alpha
Today's Market: Earnings And News Moving These 5 Stocks 10:01 a.m. Nov. 6, 2014 - Seeking Alpha
Regeneron Plunges In What Barron's Calls A Significant Disappointment: My Analysis 8:32 a.m. Nov. 6, 2014 - Seeking Alpha
6 Dividend-Paying Stocks From Around the World 10:34 a.m. Nov. 5, 2014 - Barrons.com
MannKind’s Progress Seen More Gradual 10:25 a.m. Nov. 5, 2014 - Barrons.com
What We Learned From The MannKind 3rd Quarter Conference Call 8:27 a.m. Nov. 5, 2014 - Seeking Alpha
Diabetes Analyst: Sanofi CEO's Firing May Spell Trouble for MannKind Afrezza Partnership 1:40 p.m. Nov. 4, 2014 - TheStreet.com
MannKind Corporation Stock: MNKD Third-Quarter Earnings Takeaways 6:23 a.m. Nov. 4, 2014 - InvestorPlace.com
Loading more headlines...
Press Releases on SNY
Genzyme’s Lemtrada Approved by the FDA 9:00 p.m. Nov. 14, 2014 - BusinessWire - BZX
Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma 1:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix 8:55 a.m. Nov. 4, 2014 - PR Newswire - PRF
Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis 6:00 a.m. Nov. 4, 2014 - BusinessWire - BZX
Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older 8:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sanofi 9:00 a.m. Oct. 30, 2014 - PR Newswire - PRF
Sanofi: Sanofi Delivers Business EPS Growth of 10.3% at CER 8:34 a.m. Oct. 28, 2014 - PR Newswire - PRF
New International GPCR Consortium Formed with Pharma and Academia to Advance Structural Information about G-protein Coupled Receptors 6:00 a.m. Oct. 28, 2014 - PR Newswire - PRF
Sanofi Q3 2014 Results - Interview with Jérôme Contamine 3:00 a.m. Oct. 28, 2014 - PR Newswire - PRF
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio 10:35 a.m. Oct. 20, 2014 - BusinessWire - BZX
US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis 7:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy 8:01 a.m. Oct. 16, 2014 - GlobeNewswire
New Survey Finds Differences In Attitudes About Diabetes Based On Age 8:00 a.m. Oct. 15, 2014 - PR Newswire - PRF
Genzyme Announces Winners of Patient Advocacy Leadership (PAL) Awards 8:00 a.m. Oct. 1, 2014 - BusinessWire - BZX
Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 1:00 a.m. Sept. 30, 2014 - PR Newswire - PRF
Scanning Pharma Equities - Novo Nordisk, Teva Pharma Industries, Sanofi, Valeant Pharma Intl., and Eli Lilly 9:10 a.m. Sept. 26, 2014 - PR Newswire - PRF
Genzyme Collaborates on Gene Therapy for Rare Disease that Causes Childhood Blindness 8:00 a.m. Sept. 24, 2014 - BusinessWire - BZX
Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease 8:34 a.m. Sept. 17, 2014 - PR Newswire - PRF
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies 1:00 a.m. Sept. 11, 2014 - BusinessWire - BZX
Loading more headlines...
(0)
(0)Scroll down for more posts ▼